175 related articles for article (PubMed ID: 8723139)
1. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.
Ye FQ; Allen PS; Martin WR
Mov Disord; 1996 May; 11(3):243-9. PubMed ID: 8723139
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
3. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G; Tishler TA
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
[TBL] [Abstract][Full Text] [Related]
4. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
[TBL] [Abstract][Full Text] [Related]
5. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
[TBL] [Abstract][Full Text] [Related]
6. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK
Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375
[TBL] [Abstract][Full Text] [Related]
7. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
Martin WR; Wieler M; Gee M
Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
[TBL] [Abstract][Full Text] [Related]
8. Increasing striatal iron content associated with normal aging.
Martin WR; Ye FQ; Allen PS
Mov Disord; 1998 Mar; 13(2):281-6. PubMed ID: 9539342
[TBL] [Abstract][Full Text] [Related]
9. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of regional brain iron with magnetic resonance imaging.
Martin WR
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S215-8. PubMed ID: 20082994
[TBL] [Abstract][Full Text] [Related]
11. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
[TBL] [Abstract][Full Text] [Related]
12. MRI pathology of basal ganglia in dystonic disorders.
Iwata M
Adv Neurol; 1993; 60():535-9. PubMed ID: 8420186
[No Abstract] [Full Text] [Related]
13. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
[TBL] [Abstract][Full Text] [Related]
14. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.
Boelmans K; Holst B; Hackius M; Finsterbusch J; Gerloff C; Fiehler J; Münchau A
Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788
[TBL] [Abstract][Full Text] [Related]
15. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.
Lisanby SH; McDonald WM; Massey EW; Doraiswamy PM; Rozear M; Boyko OB; Krishnan KR; Nemeroff C
J Neural Transm Suppl; 1993; 40():13-21. PubMed ID: 8294897
[TBL] [Abstract][Full Text] [Related]
16. Multispectral quantitative magnetic resonance imaging of brain iron stores: a theoretical perspective.
Jara H; Sakai O; Mankal P; Irving RP; Norbash AM
Top Magn Reson Imaging; 2006 Feb; 17(1):19-30. PubMed ID: 17179894
[TBL] [Abstract][Full Text] [Related]
17. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
Hardman CD; Halliday GM
Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
[TBL] [Abstract][Full Text] [Related]
18. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory.
Marklund P; Larsson A; Elgh E; Linder J; Riklund KA; Forsgren L; Nyberg L
Brain; 2009 Feb; 132(Pt 2):336-46. PubMed ID: 19036762
[TBL] [Abstract][Full Text] [Related]
19. Volumetry of striatum and pallidum in man--anatomy, cytoarchitecture, connections, MRI and aging.
Brabec J; Krásený J; Petrovický P
Sb Lek; 2003; 104(1):13-65. PubMed ID: 14577136
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging and spectroscopy in Parkinson's disease.
Martin WR
Adv Neurol; 2001; 86():197-203. PubMed ID: 11553978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
